Compound druggability is the property ofa compound that has the potential to be developed into a drug after preliminarypharmacodynamic studies and early pharmacokinetic characterization and safetyevaluation. The process of creating a new medication is time-consuming, risky,and lucrative.
The drug-forming research platform streamlines informationexchange and R&D between basic medicine and biology, and it aids in the developmentof a systematic R&D chain from basic research, preclinical research, andclinical efficacy evaluation to new drug production and clinical application ofinnovative drugs.
Our company provides a complete drug discovery platformfor multiple stages of compound drug development, helping customers to shortenthe development cycle of innovative drugs from laboratory synthesis to clinicalapplication.
OurDrug Forming Research Platform
Our company maintains a GLP-compliant laboratory for theinvestigation and assessment of novel medications' drug formulation research.Similarity, physical and biological features, pharmacokinetics, and toxicityare all factors in the formulation of novel medications. Several in vivo process parameters (absorption, distribution, metabolism,and excretion) of chemicals are significant markers of their drug-formingproperties during the creation of new drugs and throughout the clinicalapplication.
Our company has pharmacodynamic evaluation systems andassociated standard operating procedures for a number of disease areas, and itoffers scientific and contemporary preclinical pharmacodynamic evaluationservices in terms of toxicity, metabolism, and efficacy of novel drugs, includingmolecular, cellular, and animal holistic properties.
Our service platform includes:
- In vitro mechanism studies.
- Cellular level testing.
- Early toxicity screening of new drugs.
- Pharmacokinetic efficacy evaluation.
- Initial pharmacodynamic model evaluation.
- Early drugdevelopment screening of new drugs.
In addition, our platform offers thefollowing featured studies:
- Psychoneurological drug evaluation.
- New drug development evaluation for osteoarthritis.
- Tumor immune antitumor new drugdevelopment evaluation.
WhyChoose Our Drug Forming Research Platform?
Our platformis equipped with a full set of instrumentation for synthesis, analysis andformulation studies, including:
- Synthesis-relatedfull set of process production equipment, and crystallization workstations.
- AnalyticalHPLC, GC, LC-MS, GC-MS, TGA-DSC, Laser Particle Sizer.
- Preparation-relatedfull set of solid formulation process equipment, semi-solid formulation processequipment, transdermal diffusion instrument, dissolution instrument, etc.
Our platform can carry out the whole chain of API process research, formulation process research, quality research, registration filing technical services, and seamlessly connect non-clinical research and industrial production. Meanwhile, our platform can provide modular technical services such as high-end intermediate development, complex analytical method development and validation, crystal shape technology research, impurity characterization, and quantitative research.
For more information, please feel free to contact us.
Related Services
It should be noted that our service is only used for research, not for clinical use.
